Higher dose venlafaxine may improve response compared with standard doses in people with major depressive disorder and intolerance or non-responsiveness to SSRIs: Commentary
Version 2 2024-06-02, 13:07
Version 1 2014-10-28, 09:21
journal contribution
posted on 2024-06-02, 13:07 authored by Seetal DoddSeetal Dodd, Michael BerkMichael BerkHigher dose venlafaxine may improve response compared with standard doses in people with major depressive disorder and intolerance or non-responsiveness to SSRIs: Commentary
History
Journal
Evidence-Based Mental HealthVolume
10Pagination
17-Location
Leicester, EnglandOpen access
- Yes
ISSN
1362-0347eISSN
1468-960XLanguage
EnglishNotes
This article has been published in the BMJ Berk, Michael and Dodd, Seetal 2007, Commentary : Higher dose venlafaxine may improve response compared with standard doses in people with major depressive disorder and intolerance or non-responsiveness to SSRIs, Evidence based mental health, vol. 10, no. 1, pp. 17-17. and can also be viewed on the journal’s website at www.bmj.comPublication classification
C2.1 Other contribution to refereed journalCopyright notice
2007, BMJ Publishing GroupIssue
1Publisher
BMJ PUBLISHING GROUPUsage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC